Roche Products
| Brand Name | Generic Name | |
Actemra |
Tocilizumab |
|
Avastin |
bevacizumab |
|
Cellcept |
mycophenolate mofetil |
|
Herceptin |
trastuzumab |
|
Herceptin SC |
trastuzumab |
|
Mircera |
methoxy polyethylene glycol-epoetin beta |
|
Recormon |
epoetin beta |
|
Ristova |
Rituximab |
|
Tarceva |
erlotinib |
|
Valcyte |
valganciclovir |
|
Xeloda |
Capecitabine |
|
TAMIFLU |
oseltamivir phosphate |
|
Kadcyla |
ado-trastuzumab emtansine |
|
Gazyva |
obinutuzumab |
|
Perjeta |
pertuzumab |
|
Tecentriq▼ |
Atezolizumab |
|
Actemra |
Tocilizumab |
|
Ocrevus▼ |
Ocrelizumab |
|
Mabthera |
Rituximab |
|
Alecensa |
Alectinib |
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Health care professionals are asked to report any suspected adverse reactions at [email protected]